Curaleaf Holdings Inc. (CURA.TO) — Quality & forensics
As of 2026-10-07 — refreshed nightly. Closelooknet readings from an investment research diary, not ratings or advice.
The Closelooknet module scores
- Valuation 26
- Quality 24
- Growth 38
- Balance sheet 21
- Cash quality 34
- Capital allocation 17
- Momentum 62
Scores are computed nightly across the coverage universe and read relative to it — the methodology lives in the company-scoring explainer.
Financial forensics — the academic screens
Sits in the distress zone (below 1.81). The Z-Score estimates financial-distress risk from five balance-sheet and earnings ratios.
Nine binary fundamental-strength checks across profitability, leverage and operating efficiency.
Screens reported earnings for statistical manipulation patterns — below the −1.78 manipulation-risk threshold. A screen, not an accusation.
Continue: the CURA.TO chart & overview
FAQ · from the current data · as of 2026-10-07
Quick answers
What is Curaleaf Holdings Inc.'s Closelooknet quality reading?
The composite reads 31/100 across 7 modules, as of 2026-10-07: valuation 26, quality 24, growth 38, balance sheet 21, cash quality 34, capital allocation 17, momentum 62. Closelooknet scores are research diary readings, not ratings or investment advice.
What is Curaleaf Holdings Inc.'s Altman Z-Score?
0.90, which sits in the distress zone (below 1.81) as of 2026-10-07. The Altman Z-Score estimates financial distress risk from five balance-sheet and earnings ratios.
What is Curaleaf Holdings Inc.'s Piotroski F-Score?
3 of 9, as of 2026-10-07. The F-Score counts nine binary fundamental-strength signals across profitability, leverage and operating efficiency.
What does Curaleaf Holdings Inc.'s Beneish M-Score indicate?
-2.72 — below the −1.78 manipulation-risk threshold, as of 2026-10-07. The M-Score screens reported earnings for statistical manipulation patterns; it is a screen, not an accusation.
Related in the Closelooknet universe
then Drug Manufacturers - Specialty & Generic. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.
- ROVI.MC Laboratorios Farmaceuticos ROVIindustry
- AMRX Amneal Pharmaceuticals, Inc. Class A Common Stockindustry
- ALM.MC Almirall S.A.industry
- FAGR.BR Fagron NVindustry
- APTX.TO Apotex Health Corpindustry
- RDY Dr. Reddy’s Laboratories Ltd ADRindustry
- HCM.L HUTCHMED China Ltdindustry
- PRGO Perrigo Company PLCindustry
- UTHR United Therapeutics Corporationindustry
- TEVA Teva Pharma Industries Ltd ADRindustry
- VTRS Viatris Incindustry
- BHC.TO Bausch Health Companies Incindustry
- TAK Takeda Pharmaceutical Co Ltd ADRindustry
- HIMS Hims Hers Health Incindustry
- KNSA Kiniksa Pharmaceuticals Ltdindustry
- LNTH Lantheus Holdings Incindustry
- ALKS Alkermes Plcindustry
- DMP.DE Dermapharm Holding SEindustry
- ZTS Zoetis Incindustry
- GALDY GALDERMA GROUP AGindustry